Summary of Key Points Core Viewpoint - The convertible bonds issued by Shenzhen Chipscreen Biosciences Co., Ltd. have seen minimal conversion activity, with a significant majority remaining unconverted as of June 30, 2025. Group 1: Convertible Bond Issuance Overview - The company issued convertible bonds amounting to RMB 500 million on July 5, 2022, with a maturity period of six years until July 4, 2028 [2] - The bonds began trading on the Shanghai Stock Exchange on July 28, 2022, under the name "微芯转债" and code "118012" [2] - The initial conversion price was set at RMB 25.36 per share, adjusted to RMB 25.26 per share on June 4, 2024, due to share repurchase and cancellation [2] Group 2: Conversion Status - From April 1, 2025, to June 30, 2025, no bonds were converted into shares, resulting in a conversion amount of RMB 0 and a total of 0 shares converted, which is 0% of the total shares before conversion [1][2] - As of June 30, 2025, a cumulative total of RMB 124,000 has been converted into 4,875 shares, representing 0.0012% of the total shares before conversion [1][2] - The total amount of unconverted convertible bonds as of June 30, 2025, stands at RMB 499,876,000, accounting for 99.9752% of the total issuance [3] Group 3: Share Capital Changes - The total share capital remained unchanged at 407,796,477 shares, with no new shares issued from the convertible bonds [4]
微芯生物: 关于可转债转股结果暨股份变动的公告